Innate Immunity of the Skin: Barriers and First Responders

Introduction

The skin's innate immune system represents the body's first line of defense against pathogens—a rapid, non-specific response system that evolved long before adaptive immunity. Unlike the antigen-specific, memory-generating responses of T and B lymphocytes, innate immunity provides immediate protection through physical barriers, pattern recognition receptors, and a diverse arsenal of antimicrobial molecules and cells.

For dermatologists, understanding innate immunity is essential because disruptions in these pathways underlie conditions from atopic dermatitis (barrier/AMP dysfunction) to autoinflammatory diseases (inflammasome activation) to chronic wounds (impaired neutrophil function).

Multi-Layered Barrier

Integrated Barrier Concept

The skin barrier encompasses multiple overlapping defense layers:

Loading diagram...

Tight Junctions: Living Barrier

While the stratum corneum is the primary physical barrier, tight junctions (TJs) in the stratum granulosum provide a second, dynamic barrier.

Component	Function	Disease Relevance
Claudins	Backbone of TJ strands	Claudin-1 ↓ in AD
Occludin	TJ integrity	Barrier dysfunction
ZO-1, ZO-2	Scaffold proteins	Link to cytoskeleton
JAM-A	Junctional adhesion	Immune cell migration

Pattern Recognition Receptors (PRRs)

Conceptual Framework

Innate immunity distinguishes "self" from "non-self" through germline-encoded pattern recognition receptors (PRRs) that detect conserved microbial structures called pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs).

Loading diagram...

Major PRR Families in Skin

Loading diagram...

Toll-Like Receptors (TLRs) in Skin

TLR	Ligand	Expression in Skin	Clinical Relevance
TLR1/2	Triacyl lipopeptides	Keratinocytes, LC, DCs	Bacterial recognition
TLR2/6	Diacyl lipopeptides	Keratinocytes	S. aureus detection
TLR2	LTA, zymosan	Keratinocytes, LCs	Gram-positive, fungi
TLR3	dsRNA	Keratinocytes	Viral recognition; wound healing
TLR4	LPS	Low on keratinocytes; macrophages	Gram-negative; psoriasis
TLR5	Flagellin	Keratinocytes	Flagellated bacteria
TLR7	ssRNA	pDCs	Imiquimod target; psoriasis
TLR9	CpG DNA	pDCs	Lupus pathogenesis

TLR Signaling Pathways

Loading diagram...

Inflammasome

NLRP3: Master Inflammasome

The NLRP3 inflammasome is a cytosolic protein complex that drives IL-1β and IL-18 maturation, playing a central role in sterile inflammation and autoinflammatory diseases.

Loading diagram...

Inflammasome-Related Skin Diseases

Disease	Mechanism	Clinical Features
Cryopyrin-associated periodic syndromes (CAPS)	NLRP3 gain-of-function	Urticaria, fever, arthralgia
Familial cold autoinflammatory syndrome (FCAS)	NLRP3 mutation	Cold-triggered urticaria
Muckle-Wells syndrome	NLRP3 mutation	Urticaria, hearing loss
NOMID/CINCA	NLRP3 mutation	Severe; CNS involvement
Schnitzler syndrome	Acquired IL-1β elevation	Urticaria, monoclonal IgM
Gout	MSU crystals → NLRP3	Acute gouty arthritis
Hidradenitis suppurativa	Inflammasome activation	Nodules, abscesses

Cellular Sentinels of Innate Immunity

Keratinocytes: Non-Professional Immune Cells

Keratinocytes are far more than structural cells—they are active participants in cutaneous immunity:

Loading diagram...

Langerhans Cells (LCs)

Langerhans cells are the resident dendritic cells of the epidermis, positioned to sample the external environment.

Feature	Description
Location	Suprabasal epidermis (2-4% of epidermal cells)
Marker	CD1a+, Langerin (CD207)+, Birbeck granules
Origin	Embryonic precursors (self-renewing)
Function	Antigen uptake, processing, migration to lymph node
Unique property	Bridge innate and adaptive immunity
Disease role	Contact dermatitis, tolerance, HIV transmission

Dermal Dendritic Cells (dDCs)

Subset	Markers	Function
cDC1	CD141 (BDCA-3)+, XCR1+	Cross-presentation, Th1
cDC2	CD1c (BDCA-1)+, CD11b+	Th2, Th17 polarization
pDC (plasmacytoid)	CD123+, BDCA-2+	Type I IFN production
Inflammatory DCs	CD14+, recruited	Inflammation-induced

Mast Cells

Mast cells are tissue-resident sentinels preloaded with inflammatory mediators:

Loading diagram...

Tissue-Resident Macrophages

Dermal macrophages provide phagocytic capacity and bridge innate-adaptive immunity:

State	Markers	Function	Inducing Signals
M1 (Classical)	CD80, CD86, iNOS	Pro-inflammatory, microbicidal	IFN-γ, LPS
M2 (Alternative)	CD163, CD206, Arginase	Tissue repair, anti-inflammatory	IL-4, IL-13

Recruited Innate Effector Cells

Neutrophils

Neutrophils are the first responders to acute infection and tissue damage:

Loading diagram...

Neutrophil Extracellular Traps (NETs)

Feature	Description
Composition	DNA, histones, granule proteins
Function	Trap and kill pathogens
Trigger	Large pathogens, certain bacteria, activated platelets
Disease role	Vasculitis, SLE (anti-dsDNA), thrombosis

Natural Killer (NK) Cells

NK cells provide innate cytotoxicity and cytokine production:

Function	Mechanism	Target
Cytotoxicity	Perforin/Granzyme, FasL	Virus-infected cells, tumor cells
Cytokine release	IFN-γ, TNF	Macrophage activation
ADCC	CD16 (FcγRIII)	Antibody-coated targets

Innate Lymphoid Cells (ILCs)

ILC Family

ILCs are tissue-resident lymphocytes that lack antigen-specific receptors but mirror T helper subsets functionally:

Loading diagram...

ILC2 in Atopic Dermatitis

ILC2s are key players in type 2 inflammation in AD:

Feature	Details
Activation	TSLP, IL-33, IL-25 (epithelial alarmins)
Products	IL-5, IL-13, amphiregulin
Effects	Eosinophilia, barrier dysfunction, itch
Clinical relevance	ILC2 numbers elevated in AD lesions

Antimicrobial Effector Mechanisms

Complement System

The complement system provides:

Opsonization (C3b coating)
Chemotaxis (C3a, C5a)
Membrane attack complex (MAC, C5b-9)
Inflammation (Anaphylatoxins)

Loading diagram...

Cathelicidin (LL-37) Revisited

LL-37 exemplifies the multifunctionality of innate defense molecules:

Function	Mechanism
Direct antimicrobial	Membrane disruption
Immunomodulation	Chemotaxis, cytokine modulation
Wound healing	Keratinocyte proliferation
Angiogenesis	Endothelial cell activation
DNA complex formation	Drives IFN-α in psoriasis/lupus

Innate-Adaptive Interface

Bridging Innate and Adaptive Immunity

Loading diagram...

"Danger Model"

The danger model (Polly Matzinger) proposes that immunity responds to "danger signals" (DAMPs) from damaged tissue, not just foreign patterns:

Concept	Traditional View	Danger Model
Trigger	Foreign (non-self)	Danger (damage)
Signal	PAMPs only	PAMPs + DAMPs
Tolerance	Central deletion	Context-dependent
Relevance	Infection	Infection + sterile inflammation

Summary

Loading diagram...

Key Clinical Pearls

Topic	Pearl
TLR7	Target of imiquimod; explains its antiviral/antitumor effects
NLRP3	Gain-of-function mutations cause CAPS; treated with IL-1 blockers
ILC2	Key drivers of type 2 inflammation in atopic dermatitis
NETs	Important in vasculitis, lupus; source of autoantigens
Keratinocytes	Active immune cells, not just barrier
LL-37-DNA	Complexes drive IFN-α in psoriasis and lupus
Mast cell MRGPRX2	Explains non-IgE drug reactions (opioids, fluoroquinolones)

Cross-References

Volume 03, Chapter 5: Antimicrobial Peptides
Volume 05, Chapter 2: Adaptive Immunity
Volume 13: Inflammatory Dermatoses - Atopic dermatitis
Volume 16: Bullous Diseases - Autoimmune mechanisms

References

Nestle FO, et al. Skin immune sentinels in health and disease. Nat Rev Immunol 2009;9:679-691.
Di Meglio P, Perera GK, Nestle FO. multitasking organ: recent insights into skin immune function. Immunity 2011;35:857-869.
Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805-820.
Kim BS, et al. TSLP elicits IL-33–independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 2013;5:170ra16.
Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol 2016;16:407-420.